Literature DB >> 2519343

Genetic factors influencing the metabolism of tolbutamide.

D J Back1, M L Orme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2519343     DOI： 10.1016/0163-7258(89)90064-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  7 in total

1.  Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver.

Authors:  S Kanamitsu; K Ito; Y Sugiyama
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 2.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

3.  Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors:  Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide.

Authors:  L M Tremaine; K D Wilner; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

5.  Co-regulation of phenytoin and tolbutamide metabolism in humans.

Authors:  W Tassaneeyakul; M E Veronese; D J Birkett; C J Doecke; M E McManus; L N Sansom; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

6.  Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.

Authors:  M E Veronese; C J Doecke; P I Mackenzie; M E McManus; J O Miners; D L Rees; R Gasser; U A Meyer; D J Birkett
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 7.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Authors:  J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.